Follow
Nair Hariprasad Haritha
Nair Hariprasad Haritha
Other namesHaritha Nair
Postdoctoral Researcher
Verified email at ouhsc.edu
Title
Cited by
Cited by
Year
Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil
BS Vinod, J Antony, HH Nair, VT Puliyappadamba, M Saikia, ...
Cell death & disease 4 (2), e505-e505, 2013
1342013
Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2–Akt axis
BS Vinod, HH Nair, V Vijayakurup, A Shabna, S Shah, A Krishna, KS Pillai, ...
Cell death discovery 1 (1), 1-9, 2015
662015
Significance of nutraceuticals in cancer therapy
HH Nair, VV Alex, RJ Anto
Evolutionary Diversity as a Source for Anticancer Molecules, 309-321, 2021
122021
Proteomic analysis of the human anterior pituitary gland
SD Yelamanchi, A Tyagi, V Mohanty, P Dutta, M Korbonits, S Chavan, ...
Omics: a journal of integrative biology 22 (12), 759-769, 2018
122018
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
SUD Aiswarya, G Vikas, NH Haritha, VB Liju, A Shabna, M Swetha, ...
Frontiers in Oncology 12, 903832, 2022
92022
Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy
NH Haritha, A Nawab, V Vijayakurup, NP Anto, VB Liju, VV Alex, ...
Frontiers in oncology 11, 656804, 2021
82021
Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis
S Mohammed, N Thadathil, P Ohene-Marfo, AL Tran, M Van Der Veldt, ...
Molecular Cancer Research 21 (9), 933-946, 2023
72023
Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma
M Swetha, CK Keerthana, TP Rayginia, LR Nath, NH Haritha, A Shabna, ...
Pharmaceuticals 15 (5), 636, 2022
52022
Blockade of uttroside b-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma
LR Nath, M Swetha, V Vijayakurup, AK Thangarasu, NH Haritha, ...
Frontiers in Oncology 12, 812598, 2022
42022
Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy (vol 11, 656804, 2021)
NH Haritha, A Nawab, V Vijayakurup, NP Anto, VB Liju, VV Alex, ...
FRONTIERS IN ONCOLOGY 13, 2023
12023
Blocking necroptosis reduces inflammation and tumor incidence in a mouse model of diet-induced hepatocellular carcinoma
S Mohammed, N Thadathil, AL Tran, M Van Der Veldt, C Georgescu, ...
bioRxiv, 2022.08. 03.502666, 2022
12022
Etiological Insights into TNBC and their Related Catastrophic Risks
HH Nair, RJ Anto
Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer, 1, 2023
2023
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy
NH Haritha, A Nawab, V Vijayakurup, NP Anto, VB Liju, VV Alex, ...
Frontiers in Oncology 13, 2023
2023
Kaempferide induces apoptosis in cervical cancer by attenuating the HPV oncoproteins, E6 and E7
LR Nath, VV Alex, SU Aiswarya, TP Rayginia, NH Haritha, CK Keerthana, ...
bioRxiv, 2023.05. 19.541414, 2023
2023
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma
LR Nath, M Swetha, V Vijayakurup, AK Thangarasu, NH Haritha, ...
Frontiers in Oncology 12, 991401, 2022
2022
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
SUD Aiswarya, G Vikas, NH Haritha, VB Liju, A Shabna, M Swetha, ...
Frontiers in Oncology 12, 989283, 2022
2022
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma
AK Thangarasu, K Kalimuthu, R Towner, S Sundaram, V Vijayakurup, ...
Frontiers Media SA, 2022
2022
Triple negative breast cancer: The therapeutic windows yet to be opened?
N Haritha H, A Ruby John
Science Letters 4 (175), 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–18